Biogen plans to launch gene therapy and gene editing collaboration with University of Pennsylvania MarketWatch Biogen Inc. BIIB, +1.61% said Monday morning it would collaborate with the University of Pennsylvania on an up to $2 billion project to develop gene therapy and gene editing programs and technologies. The effort will have a particular focus on ... |
For more information, please visit
http://news.google.com/news/url?sa=t&fd=[...]and-gene-editing-collaboration